Yulia A. Abdullina, Anastasia V. Kabanova, Ayrat R. Hayatov, Svetlana N. Egorova
{"title":"ANALYSIS OF THE AVAILABLE SOLVENTS AND DILUENTS FOR INJECTABLES USED IN PEDIATRIC PRACTICE","authors":"Yulia A. Abdullina, Anastasia V. Kabanova, Ayrat R. Hayatov, Svetlana N. Egorova","doi":"10.20969/vskm.2024.17(2).14-22","DOIUrl":null,"url":null,"abstract":"Introduction. Solvents and diluents for parenteral medicines are widely used in pediatric hospitals and occupy leading positions in terms of the number of packages in purchases. Injectables are prescribed to children in reduced volumes, as compared to adults. In this regard, it is relevant to study the solvents and diluents available for parenteral administration of drugs in terms of packaging types and reduced volumes for use in pediatrics in the domestic pharmaceutical market. Aim of the study is to analyze the available solvents and diluents for parenteral medicines, such as water for injection, isotonic solutions of sodium chloride, Ringer, and Ringer lactate, on the Russian pharmaceutical market and in a multidisciplinary children’s hospital. Material and Methods. Objects of the study were data from the State Register of Medicines of Russia, the requisition slips of Medical Devices and Pharmacy of Tatarstan for medicines shipped from a warehouse to the Republic Clinical Children’s Hospital of the Ministry of Health of the Republic of Tatarstan in 2022, the price lists for medicines of pharmaceutical wholesalers (September 2023), and the data from scientific publications. Results and Discussion. The data obtained indicate that the regional pharmaceutical market has about twice as many options for the supply of medicinal solvents and diluents than in a children’s multidisciplinary hospital, and this allows expanding the range of this group of medicines. It can be assumed that pharmaceutical industrial enterprises do not produce a full range of options for the volume of primary packaging of solvents and diluents registered in the State Register of Medicines. Conclusions. In Russia, reduced volumes (20-30 ml) of 0.9% sodium chloride, 5% glucose, Ringer, and Ringer lactate solutions in vials for intravenous drip administration in pediatric practice are neither registered nor produced. The depth coefficient of the assortment of the studied solvents and diluents for parenteral medicines in relation to the volume of primary packaging in a children’s multidisciplinary hospital is 0.102. This indicates the need for medical organizations to consider the possibilities of the pharmaceutical market when drawing up applications for the supply of medicines.","PeriodicalId":110361,"journal":{"name":"The Bulletin of Contemporary Clinical Medicine","volume":"71 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Bulletin of Contemporary Clinical Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20969/vskm.2024.17(2).14-22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction. Solvents and diluents for parenteral medicines are widely used in pediatric hospitals and occupy leading positions in terms of the number of packages in purchases. Injectables are prescribed to children in reduced volumes, as compared to adults. In this regard, it is relevant to study the solvents and diluents available for parenteral administration of drugs in terms of packaging types and reduced volumes for use in pediatrics in the domestic pharmaceutical market. Aim of the study is to analyze the available solvents and diluents for parenteral medicines, such as water for injection, isotonic solutions of sodium chloride, Ringer, and Ringer lactate, on the Russian pharmaceutical market and in a multidisciplinary children’s hospital. Material and Methods. Objects of the study were data from the State Register of Medicines of Russia, the requisition slips of Medical Devices and Pharmacy of Tatarstan for medicines shipped from a warehouse to the Republic Clinical Children’s Hospital of the Ministry of Health of the Republic of Tatarstan in 2022, the price lists for medicines of pharmaceutical wholesalers (September 2023), and the data from scientific publications. Results and Discussion. The data obtained indicate that the regional pharmaceutical market has about twice as many options for the supply of medicinal solvents and diluents than in a children’s multidisciplinary hospital, and this allows expanding the range of this group of medicines. It can be assumed that pharmaceutical industrial enterprises do not produce a full range of options for the volume of primary packaging of solvents and diluents registered in the State Register of Medicines. Conclusions. In Russia, reduced volumes (20-30 ml) of 0.9% sodium chloride, 5% glucose, Ringer, and Ringer lactate solutions in vials for intravenous drip administration in pediatric practice are neither registered nor produced. The depth coefficient of the assortment of the studied solvents and diluents for parenteral medicines in relation to the volume of primary packaging in a children’s multidisciplinary hospital is 0.102. This indicates the need for medical organizations to consider the possibilities of the pharmaceutical market when drawing up applications for the supply of medicines.
导言。用于肠外药物的溶剂和稀释剂在儿科医院被广泛使用,并在采购包装数量上占据领先地位。与成人相比,儿童的注射剂用量较少。因此,有必要对国内医药市场上用于儿科非肠道给药的溶剂和稀释剂的包装类型和减量情况进行研究。本研究旨在分析俄罗斯医药市场和一家多学科儿童医院中可用的肠外给药溶剂和稀释剂,如注射用水、氯化钠等渗溶液、林格溶液和乳酸林格溶液。材料和方法。研究对象是《俄罗斯国家药品登记册》、《鞑靼斯坦医疗器械和药房》(Medical Devices and Pharmacy of Tatarstan)2022年从仓库运往鞑靼斯坦共和国卫生部共和国临床儿童医院的药品申购单、药品批发商的药品价目表(2023年9月)以及科学出版物中的数据。结果与讨论所获得的数据表明,地区医药市场上的药用溶剂和稀释剂供应选择比儿童多科医院多出一倍左右,这使得这类药物的供应范围得以扩大。可以认为,制药工业企业并没有生产在国家药品登记处登记的溶剂和稀释剂初级包装量的全部选择。结论在俄罗斯,用于儿科静脉滴注的 0.9%氯化钠、5%葡萄糖、林格和林格乳酸盐溶液的小容量瓶(20-30 毫升)既没有注册,也没有生产。在一家儿童多学科医院中,所研究的肠外药品溶剂和稀释剂品种与主包装容量的深度系数为 0.102。这表明,医疗机构在起草药品供应申请时,需要考虑医药市场的可能性。